Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Study of Short-term Antibiotic for Pyelonephritis in Women

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Women between 18 and 65 years old~* Diagnosis of Acute Uncomplicated Pyelonephritis~* Patient obliged to participate in the French national health and pensions system.~* Patient who have read, understood and signed the consent~Exclusion Criteria:~* Women who are pregnant~* Men~* One of these risk factor who define a complicated pyelonephritis:~Medical history of uro-nephrology problem Nephropathy Obstructive Uropathy Vesicoureteral reflux Post mictinal residue \> 100mL Urinary fistula Catheter vesicle and urethral Kidney transplantation Immunodeficiency Diabetes~* Recurrent pyelonephritis~* Allergy of betalactam or cephalosporin~* History of hypersensitivity reactions to antibiotic medications~* Patient in terminal care~* Trouble of cognitive function~* Patient deprive of judicial or administrative freedom~* Patient participating to another trial~* Refusal to participate to the trial

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).